Skip to main content
Press Releases

MedImpact Launches Claria™, a Distinctively New Approach to Delivering Pharmacy Benefits

Claria transforms PBM economics by giving plan sponsors the transparency, control, and predictability they need to maximize their investment in medications

SAN DIEGO, CA—September 29, 2026—MedImpact, the nation’s largest independent pharmacy benefit and health solutions company, today introduced Claria™, an industry-first approach that transforms PBM economics by giving plan sponsors the increased transparency, control, and predictability they need to confidently manage pharmacy spend in today’s healthcare landscape.

“Claria provides a new way of delivering pharmacy benefits to our clients. It brings together the scale of MedImpact’s organization to deliver competitive economics with the flexibility for clients to choose the model that meets their needs. Most importantly, Claria is designed to align our compensation with our clients’ goals of managing pharmacy spend, controlling trend, and improving access to care,” said MedImpact Executive Vice President Zach Johnson. “Plan sponsors gain visibility into the true net cost of medications, greater control over clinical strategies, and enhanced budget predictability.”

Predictability Without Compromise. We believe payers should not have to choose between rebates, flexibility, and financial certainty. That’s why Claria offers four configurable models, all with transparent pricing, to meet each organization’s unique needs:

  • Claria Direct — Designed for organizations that want to maximize control over their pharmacy strategy, Claria Direct offers the ability to customize formularies, networks, dispensing channels, and value-added services.
  • Claria Assure — Offers modernized pricing strategies with the flexibility to customize program features all with the financial confidence of guarantees.
  • Claria One — A PMPM guarantee and a formulary strategy built around lower-cost therapeutic options designed for organizations seeking the highest level of financial accountability and cost management.
  • Claria Align — By guaranteeing a plan’s PMPM spend dollar for dollar, Claria Align delivers the highest level of accountability in the portfolio and is designed to deliver the lowest pharmacy costs.

Informed Decision Making. Claim-level rebate transparency provides visibility into the net cost of every medication, enabling more informed financial and clinical decision-making.

Plan Control Over Pharmacy Strategy. Plans may implement formulary, utilization management, biosimilar, and network strategies based on their organization’s needs.

Aligned Incentives. Claria aligns PBM compensation with services and solutions rather than drug mix, creating a stronger partnership with a continued focus on managing cost, trend, and outcomes.

Member Affordability. We recognize that our clients value and prioritize affordable pharmacy benefits for their members. Claria will position MedImpact to lay the foundation that aligns and empowers us to build pharmacy plans that prefer the lowest cost, and therapeutically appropriate medication now more than ever.

“MedImpact has been an independent company for nearly 40 years, and we have been committed to delivering clarity and control to our clients since our inception,” said Johnson. “With Claria, we are taking that commitment to an entirely new level and providing clients with even greater flexibility and freedom to navigate today’s healthcare landscape.” 

Learn more about Claria.

SHARE
RESOURCES
Read on
Keep up to date on the latest in the industry.
Press Releases
Pharmacy benefits executive will help the company communicate its affordability, technology, and clinical solutions to a healthcare industry undergoing change
Press Releases
HCG X program provides payers 80.6% PMPQ savings and a 5:1 ROI in year one
Press Releases
Leveraging supply chain innovation and award-winning lifestyle management program, new solutions deliver lower costs, improved clinical care, and greater member access
Press Releases
By re-engineering the drug supply chain and formularies, Patel and the MedImpact team are increasing transparency, predictability and affordability

Ready for clarity?